The research, led by Newton and colleagues and published in Nature Structural & Molecular Biology, takes advantage of a long-standing puzzle in receptor biophysics. Full agonists such as glutamate drive AMPA receptors to high open probabilities, whereas partial agonists, including the willardiine derivatives that bind in the same ligand-binding pocket but occupy it incompletely, produce smaller responses. Electrophysiologists have known for years that partial agonists generate smaller currents largely because they destabilize the open state rather than slow channel opening itself, but the structural intermediates through which agonist efficacy is transduced into pore opening were poorly defined. The new work closes this gap by trapping the receptor in these intermediates and imaging them directly, revealing that the pre-active state is not a vague abstraction but a discrete, resolvable structural ensemble with its own characteristic domain arrangement.

To visualize the pathway, the team employed time-resolved cryo-electron microscopy, a technique that flash-freezes protein samples at defined intervals after agonist application, effectively capturing molecular movies of the receptor as it transitions between states. By applying full and partial agonists and freezing the samples at early time points, the researchers were able to arrest the receptor population at different stages along the activation trajectory. Classification and reconstruction of the resulting particle images then separated the heterogeneous mixtures into distinct conformational classes corresponding to the resting, pre-active, and open states. This strategy allowed the authors to assemble an ordered sequence of structures that collectively describe the gating cycle, something that conventional single-state cryo-EM snapshots had been unable to deliver because the intermediate states are transient and sparsely populated at equilibrium.

The resulting structures reveal that AMPA receptor activation is a highly coordinated, multi-step process. In the resting state, the extracellular ligand-binding domains, which form a dimer-of-dimers architecture in the tetrameric receptor, adopt an extended configuration, and the transmembrane channel-lining helices are held shut. Upon agonist binding, each ligand-binding domain clamshell closes around its ligand, but the structures show that clamshell closure alone is not sufficient to open the pore. Instead, the receptor passes through the pre-active state, in which the ligand-binding domains have begun to rearrange and the interfaces between subunits have weakened in a specific, asymmetric pattern, while the transmembrane gate remains closed. This intermediate represents the structural link between ligand binding and gate opening, and its resolution provides the first complete structural description of how binding energy is accumulated before the pore expands.

One of the most striking findings of the study concerns the role of symmetry and subunit cooperativity. AMPA receptors are tetramers assembled from four subunits, and the new structures demonstrate that the four ligand-binding domains do not move in lockstep. Instead, activation proceeds through partially occupied and asymmetric configurations in which different subsets of subunits contribute to the driving force for opening at different stages. Full agonists stabilize configurations in which all four ligand-binding domains have closed and the intersubunit interfaces have rearranged sufficiently to pull the M3 gate helices apart. Partial agonists, by contrast, fail to stabilize the same set of interactions, leaving the receptor more frequently stranded in or near the pre-active state rather than progressing to the open state. This observation provides a direct structural explanation for the classical electrophysiological finding that partial agonists reduce open probability without substantially slowing activation kinetics.

The study also clarifies how the energy of ligand binding is transmitted across the membrane. The structures trace a continuous mechanical pathway from the ligand-binding core, through the linker peptides that connect the ligand-binding domains to the transmembrane region, and into the M3 segments that form the activation gate. In the pre-active state, this pathway is under tension: the ligand-binding cores have moved, but the gate has not yet followed. The authors’ analysis shows that the transition from the pre-active state to the open state involves a concerted rearrangement of the linkers and an expansion of the gate, which widens the ion-conducting pore to a diameter compatible with rapid cation flow. The completeness of this structural trajectory, from free receptor to agonist-bound pre-active state to open channel, means that researchers can now assign specific conformational changes to specific steps in the energy landscape of gating.

These findings have broad implications for understanding both normal synaptic transmission and neurological disease. AMPA receptor dysfunction has been implicated in epilepsy, amyotrophic lateral sclerosis, Alzheimer’s disease, and a range of psychiatric conditions, and the receptors are major drug targets. Positive allosteric modulators of AMPA receptors, known as ampakines, act by stabilizing specific states along the gating pathway, and allosteric toxins and endogenous modulators likewise exert their effects by shifting the energetic balance between closed, pre-active, and open configurations. With the pre-active state now structurally defined, drug developers have a new and strategically important conformational target: molecules that stabilize or destabilize this intermediate could fine-tune synaptic strength with an unprecedented degree of control, potentially treating hyperexcitability or cognitive impairment by adjusting how easily receptors cross the final activation barrier.

The work also serves as a methodological demonstration of what time-resolved cryo-electron microscopy can achieve for ion channel biology. AMPA receptors, like many ligand-gated channels, are dynamic machines whose most interesting states are the least stable ones. By combining rapid mixing and freezing with sophisticated image classification, the study shows that even sparsely populated, millisecond-scale intermediates can be captured and resolved. The approach, the authors note, should be readily transferable to other members of the ionotropic glutamate receptor family, including NMDA and kainate receptors, as well as to related tetrameric channels, promising a more complete mechanistic picture of excitatory signaling throughout the nervous system. It also complements electrophysiology and molecular dynamics simulations by anchoring computational models to experimentally determined intermediate structures.

In synthesizing full and partial agonist data across multiple time points, the study delivers what receptor biophysicists have sought since AMPA receptors were first cloned: a structurally grounded, stepwise model of activation that connects ligand chemistry to pore conductance. The pre-active state, once an enigmatic placeholder in kinetic schemes, is now a defined three-dimensional entity with measurable intersubunit interfaces, linker tensions, and gate geometry. As researchers begin to exploit this intermediate in drug discovery and mutagenesis studies, the complete gating pathway of AMPA receptors will likely serve as a paradigm for how molecular machines convert chemical signals into electrical events, a conversion that underlies every thought, sensation, and movement the brain produces.

Subject of Research: Structural mechanism of AMPA receptor gating and pre-activation revealed by time-resolved cryo-electron microscopy

Article Title: Pre-activation and gating pathway of AMPA receptors revealed by full and partial agonists

Article References: Newton, T. P., Aktolun, M., Yelshanskaya, M. V., Alekseev, A. A., Yen, L. Y., Gangwar, S. P., Sobolevsky, I. A., Kurnikova, M. G., & Sobolevsky, A. I. (2026). Pre-activation and gating pathway of AMPA receptors revealed by full and partial agonists. Nature Structural & Molecular Biology. https://doi.org/10.1038/s41594-026-01882-9

Image Credits: AI Generated

DOI: 10.1038/s41594-026-01882-9

Keywords: AMPA receptors, pre-active state, gating pathway, cryo-electron microscopy, full agonists, partial agonists, ligand-binding domain, ion channels, synaptic transmission, neuroscience, Pre-activation, gating

GPCRs represent the largest family of membrane receptors and are targets for roughly one-third of all marketed drugs, mediating a broad spectrum of physiological responses. Despite extensive study, the molecular underpinnings of how structurally distinct ligands produce differential signaling responses through the same receptor have remained obscure. Traditional structural methods typically capture static snapshots under equilibrium conditions, missing critical transient conformations that may govern signaling dynamics.

To bridge this knowledge gap, the investigative team focused on the MOR bound to three types of ligands categorized as partial, full, and super-agonists—each producing distinct degrees of receptor activation and downstream signaling. By applying TR cryo-EM to samples rapidly progressing through GTP-induced activation of the heterotrimeric G protein Gi (Gαiβγ), they visualized ensembles of receptor-G protein complexes at discrete time points, effectively generating snapshots of the activation trajectory in real time.

Remarkably, this technique uncovered a series of intermediate states previously undetected in static structural studies. Among these, one intermediate state provided crucial evidence linking receptor dynamics in transmembrane helices 5 and 6 to ligand efficacy. Notably, ligands with higher efficacy induced greater conformational flexibility within these helices, suggesting that dynamic structural plasticity is a key determinant of productive G-protein coupling and activation.

The findings also reveal ligand-dependent differences in state occupancy, signifying that ligands modulate the energy landscape of receptor conformations, thereby altering the population distribution of signaling states. This adds new dimension to the classic pharmacological concept of efficacy by presenting a structural correlate: more efficacious ligands promote receptor states that favor faster and more robust G-protein activation.

Furthermore, by extending their analysis to compare the GTP-dependent activation mechanisms of Gi versus Gs protein families, the researchers illuminated fundamental mechanistic disparities that likely account for their distinct kinetics and signaling profiles. These insights have profound implications for understanding biased agonism and selective therapeutic targeting of GPCRs.

Corroborated by extensive molecular dynamics (MD) simulations, the experimental data emphasize how receptor flexibility modulates the allosteric communication between ligand-binding pockets and intracellular signaling interfaces. The simulations align with TR cryo-EM observations, highlighting increased mobility in TM helices corresponding to higher ligand efficacy states. This synergy between structural snapshots and computational modeling presents a powerful framework for comprehending GPCR dynamics.

Complementing the structural and computational work, single-molecule fluorescence resonance energy transfer (smFRET) assays provided real-time kinetic data, bringing temporal resolution to the conformational transitions of receptor and G-protein complexes. These measurements support the notion that partial agonists may induce kinetic traps—intermediate states that slow G-protein activation without fully stabilizing the active receptor conformation—shedding light on the molecular basis of partial signaling efficacy.

Overall, this study marks a significant leap in GPCR research by establishing a mechanistic relationship between ligand binding, receptor conformational dynamics, and G-protein activation kinetics. The ability to capture non-equilibrium states through TR cryo-EM opens new vistas for drug discovery, permitting the design of ligands that finely tune receptor function via targeted modulation of conformational landscapes.

The implications of this work extend well beyond opioid pharmacology. Given the ubiquity of GPCRs in human physiology, understanding the kinetic and dynamic aspects of receptor activation can revolutionize approaches to treating myriad conditions, from metabolic diseases to neurological disorders. Furthermore, it challenges the conventional equilibrium-centric paradigms, emphasizing the importance of temporal dynamics in receptor pharmacology.

Intriguingly, these findings also inspire the notion of ‘kinetic pharmacology,’ where the timescales of receptor state transitions become as critical as thermodynamic stability, adjusting how we think about agonist design and receptor signaling bias. By exploiting transient intermediates and dynamic landscapes, drug developers might now craft molecules with desired kinetic profiles, optimizing therapeutic efficacy and minimizing side effects.

This research leverages state-of-the-art cryo-EM instrumentation capable of freezing biological complexes at precise time intervals following ligand-induced activation events. The capability to image assemblies at sub-millisecond to millisecond timescales is revolutionizing the structural biology field, transforming once invisible transient intermediates into visualized entities.

In summary, this multidisciplinary investigation provides a blueprint for integrating experimental and computational approaches to dissect the complex choreography of receptor activation. It uncovers the hidden mechanistic subtleties that govern how distinct ligands shape GPCR signaling, offering a transformative outlook on receptor pharmacology and opening pathways toward rational drug design strategies informed by structural dynamics rather than static snapshots.

As opioid therapies remain both critically important and therapeutically challenging due to side effects and tolerance development, such detailed mechanistic insights into MOR function could facilitate the creation of safer analgesics. By harnessing the dynamic interplay of receptor conformations and ligand efficacy, future drugs may achieve greater specificity in modulating pain pathways while minimizing adverse effects.

The scientific community now stands at the cusp of a new era where non-equilibrium structural biology, empowered by TR cryo-EM and allied technologies, will unravel the complexities of cellular signaling. This breakthrough paves the way for developing next-generation therapeutics designed with exquisite precision to modulate receptor states dynamically, potentially revolutionizing treatment paradigms across diseases driven by GPCR dysfunction.

Subject of Research:
Molecular mechanisms of ligand-dependent activation of the μ-opioid receptor and conformational dynamics of G-protein coupling.

Article Title:
Non-equilibrium snapshots of ligand efficacy at the μ-opioid receptor.

Article References:
Robertson, M.J., Modak, A., Papasergi-Scott, M.M. et al. Non-equilibrium snapshots of ligand efficacy at the μ-opioid receptor. Nature (2025). https://doi.org/10.1038/s41586-025-10056-4

Image Credits:
AI Generated

In the realm of muscle contraction and cellular motility, myosin has long been recognized as a powerful motor protein. The mechanism by which it travels along actin filaments, primarily driven by ATP hydrolysis, is not only fundamental but also compelling. Studies have sequentially elucidated the structural transitions from unbound primed myosin to primed actomyosin and finally to the post-power stroke states. Each transition mirrors minute yet significant alterations in both the myosin and actin structures that facilitate this incredible force-generating capacity.

For instance, the preliminary weak binding of primed myosin to actin underlines a vital aspect of this interaction—the electrostatic complementarity between the positively charged residues of myosin’s loop 2 and the negatively charged residues in actin subdomain 1. This binding step is crucial as it positions the myosin lever arm in close proximity to the actin filament. These initial interactions trigger subsequent conformational changes within the myosin structure, setting the stage for force production.

As myosin engages actin, the interplay between the hydrophobic and ionic interactions leads to greater stabilization of the myosin’s light chain domain, referred to as L50. This stabilization is pivotal as it transitions myosin to the primed actomyosin state, characterized by a cocked position of the upper 50-kDa domain. The delicate balance of mechanical strain and molecular stabilization highlights the sophisticated choreography that occurs at the molecular level.

The transition from primed to the post-power stroke (postPS) state unveils the underlying principle of cleft closure in myosin. This mechanism is critically linked to the hydrolysis of ATP and results in a strong-binding interface necessary for enduring force production. As myosin experiences the lever swing, the transducer and relay helix undergo substantial reshaping, ultimately leading to the power stroke—a kinetic phenomenon observed in real-time through advanced imaging techniques.

Delving deeper into the mechanism of ATPase activation, one can observe how the N-terminal residues of actin play a crucial role. These residues become ordered upon binding with myosin, a structural change that significantly enhances actin’s ability to activate myosin’s ATPase activity. This rearrangement underscores the interdependence of myosin and actin as they engage in a dynamic partnership, critical for cellular movement.

Moreover, it is essential to highlight that while the actin structure remains relatively conserved through its various states, the motions of the N-terminal residues reveal a remarkable plasticity. This adaptability is central to the coordination required for efficient ATP hydrolysis and subsequent dissociation of inorganic phosphate (P_i). The rigorous timing of these events contributes to the overall efficiency of the power stroke.

The disassociation of P_i, a vital step catalyzed by the mechanical strain imparted by myosin actin binding, is a critical point of focus. The intricate dynamics showcase how myosin releases P_i in a carefully orchestrated fashion, illustrating the advantages of the energy economy present in cellular processes. This delay in phosphate release provides insights into how kinetic parameters govern the interaction dynamics, allowing for a seamless transition during muscle contraction.

Interestingly, the presence of an axial load introduces a layer of complexity in myosin’s functionality. Despite external resistance, myosin remains effectively coupled between cleft closure and lever swing, an observation that speaks to the motor protein’s ability to maintain its grip on actin filaments. Such resilience ensures that the force output remains consistent, underscoring how molecular mechanics operate with precision even under stress.

Fascinatingly, the serendipitous nature of these biochemical interactions illustrates a broader principle in molecular biology—the concept of cooperative binding. Both myosin and actin exemplify how slight changes in conformation can lead to significant functional outputs, a principle that resonates throughout numerous biological pathways.

The study of the myosin-actin interaction not only expands our comprehension of muscle physiology but also offers potential avenues in biotechnology and medicine. Understanding this mechanism can inspire new interventions in muscular disorders and provide groundwork for bioengineering applications where actin-myosin systems could be manipulated for desired outcomes.

Ultimately, the observations gleaned from this research provide a glimpse into the future of molecular biology and the vast potential for discovering novel therapeutic strategies and building synthetic biological systems. As our understanding of these molecular machines continues to evolve, we find ourselves at the threshold of groundbreaking discoveries that could transform how we approach biological function and disease.

By demystifying the mechanics underlying myosin and actin interactions, researchers are paving the way for innovations that promise to enhance our capabilities in various fields, from regenerative medicine to robotics. The journey of exploring these molecular interactions is just beginning, inviting further inquiry and exploration into the life-sustaining rhythms of cells.

In conclusion, myosin’s mechanism of movement, facilitated by actin catalysis, reflects the intricate balance of molecular forces that drive cellular dynamics. The continuous interplay between structure and function illustrates a profound aspect of life at the nanoscale, embodying the elegance and complexity that define biological systems. As we unravel these molecular mysteries, the impact of our discoveries holds the potential to redefine the interface between biology and technology, inspiring a new generation of scientists in their quest to understand and apply the wonders of life.

Subject of Research: Myosin and Actin Interactions in Muscle Contraction

Article Title: Swinging lever mechanism of myosin directly shown by time-resolved cryo-EM

Article References:
Klebl, D.P., McMillan, S.N., Risi, C. et al. Swinging lever mechanism of myosin directly shown by time-resolved cryo-EM. Nature (2025). https://doi.org/10.1038/s41586-025-08876-5

Image Credits: AI Generated

DOI: 10.1038/s41586-025-08876-5

Keywords: Myosin, actin, ATPase activation, muscle contraction, cryo-EM, molecular mechanics, cell motility, structural biology.